Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - (prefilled syringe) diphtheria toxoid; (prefilled syringe) filamentous haemagglutinin; (prefilled syringe) pertussis toxoid; (prefilled syringe) poliovirus (inactivated) - type 1 (mahoney); (prefilled syringe) poliovirus (inactivated) - type 2 (mef-1); (prefilled syringe) poliovirus (inactivated) - type 3 (saukett); (prefilled syringe) tetanus toxoid; (vial) haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein; (vial) tetanus protein (prp-t) - injection, powder, for suspension - (prefilled syringe) diphtheria toxoid min. 20 iu (30 lf)/0.5 ml; (prefilled syringe) filamentous haemagglutinin 25 μg/0.5 ml; (prefilled syringe) pertussis toxoid 25 μg/0.5 ml; (prefilled syringe) poliovirus (inactivated) - type 1 (mahoney) 40 du/0.5 ml; (prefilled syringe) poliovirus (inactivated) - type 2 (mef-1) 8 du/0.5 ml; (prefilled syringe) poliovirus (inactivated) - type 3 (saukett) 32 du/0.5 ml; (prefilled syringe) tetanus toxoid min. 40 iu (10 lf) /0.5 ml; (vial) haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein 10 μg/0.5 ml; (vial) tetanus protein (prp-t) 18 - 30 μg/0.5 ml

Philippines - English - FDA (Food And Drug Administration)

medical vaccines online deliveries; distributor: medical vaccines online deliveries - diphtheria, tetanus, pertussis, hepatitis b and haemophilus influenzae type b conjugate vaccine (adsorbed) (see reverse for complete formulation) - suspension for injection (i.m.) - 30 iu, 40 iu,4 iu, 10 mcg, 10 mcg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: medical vaccine online deliveries; distributor: rbc-mdc corporation with trade name rbcj pharmacy - diphtheria, tetanus, pertussis, hepatitis b and haemophilus influenzae type b conjugate vaccine (adsorbed) - suspension for injection (im) - 0.5 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - meningococcal polysaccharide group c, quantity: 5 microgram; meningococcal polysaccharide group y, quantity: 5 microgram; meningococcal polysaccharide group w135, quantity: 5 microgram; meningococcal polysaccharide group a, quantity: 5 microgram; tetanus toxoid, quantity: 44 microgram - injection, powder for - excipient ingredients: sucrose; trometamol hydrochloride - nimenrix is indicated for active immunisation of individuals from 6 weeks of age against invasive meningococcal diseases caused by neisseria meningitidis groups a, c, w-135 and y.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - bordetella pertussis + diphtheria toxoid + haemophilus influenzae type b conjugated + hepatitis b surface antigen + tetanus toxoid - vaccine - 4 iu + 30 iu + 10 mcg + 10 mcg + 60 iu/.5 ml

Canada - English - Health Canada

sanofi pasteur limited - pertussis toxoid; filamentous haemagglutinin; fimbriae; pertactin; diphtheria toxoid; tetanus toxoid; inactivated poliomyelitis vaccine (d.c.o.) type 1 mahoney; inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1; inactivated poliomyelitis vaccine (d.c.o.) type 3 saukett; haemophilus influenzae type b-prp; tetanus protein - liquid - 20mcg; 20mcg; 5mcg; 3mcg; 15lf; 5lf; 40unit; 8unit; 32unit; 10mcg; 30mcg - pertussis toxoid 20mcg; filamentous haemagglutinin 20mcg; fimbriae 5mcg; pertactin 3mcg; diphtheria toxoid 15lf; tetanus toxoid 5lf; inactivated poliomyelitis vaccine (d.c.o.) type 1 mahoney 40unit; inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1 8unit; inactivated poliomyelitis vaccine (d.c.o.) type 3 saukett 32unit; haemophilus influenzae type b-prp 10mcg; tetanus protein 30mcg - vaccines

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - haemophilus influenza type b conjugate vaccine - lyophilized powder for injection - 10mcg + 0.5ml

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - haemophilus influenza type b conjugate vaccine - lyophilized powder for injection - 10mcg + 0.5ml

Namibia - English - Namibia Medicines Regulatory Council

serum institute of india ltd - purified capsular polysaccharide; tetanus toxoid as carrier protein - injection - each dose of 0.5 ml contains 10 mcg of ; purified capsular polysaccharide and 19 to; 33 mcg tetanus toxoid as carrier protein

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - haemophilus influenzae type b polysaccharide 10ug (conjugated to tetanus protein.); bordetella pertussis, inactivated 4 [iu]; diphtheria toxoid, adsorbed 30 [iu]; tetanus toxoid 60 [iu] - solution for injection - active: haemophilus influenzae type b polysaccharide 10ug (conjugated to tetanus protein.) excipient: sucrose tris-bp active: bordetella pertussis, inactivated 4 [iu] diphtheria toxoid, adsorbed 30 [iu] tetanus toxoid 60 [iu] excipient: aluminium hydroxide sodium chloride thiomersal